Sphingosine Kinase 2 in Autoimmune/Inflammatory Disease and the Development of Sphingosine Kinase 2 Inhibitors

This publication has 55 references indexed in Scilit:

• (R)-FTY720 methyl ether is a specific sphingosine kinase 2 inhibitor: Effect on sphingosine kinase 2 expression in HEK 293 cells and actin rearrangement and survival of MCF-7 breast cancer cells
  Cellular Signalling, 2011
• STAT3-induced S1PR1 expression is crucial for persistent STAT3 activation in tumors
  Nature Medicine, 2010
• Sphingosine‐1‐phosphate produced by sphingosine kinase 2 in mitochondria interacts with prohibitin 2 to regulate complex IV assembly and respiration
  The FASEB Journal, 2010
• The S1P1-mTOR axis directs the reciprocal differentiation of TH1 and Treg cells
  Nature Immunology, 2010
• Pharmacology and Antitumor Activity of ABC294640, a Selective Inhibitor of Sphingosine Kinase-2
  The Journal of Pharmacology and Experimental Therapeutics, 2010
• FTY720 (fingolimod) in Multiple Sclerosis: therapeutic effects in the immune and the central nervous system
  British Journal of Pharmacology, 2009
• Divergent roles of sphingosine kinases in kidney ischemia–reperfusion injury
  Kidney International, 2009
• A role for sphingosine kinase 1 in dextran sulfate sodium‐induced colitis
  The FASEB Journal, 2008
• Principles of bioactive lipid signalling: lessons from sphingolipids
  Nature Reviews Molecular Cell Biology, 2008
• Suppression of Ulcerative Colitis in Mice by Orally Available Inhibitors of Sphingosine Kinase
  Digestive Diseases and Sciences, 2007